drugset / Trial / NCT07065617
A Study to Test How BI 1819479 is Taken up and Processed by the Body
Non-randomizedSequentialOpen-labelTreatment
Summary
This trial is intended to investigate the mass balance, metabolism, and basic pharmacokinetics of BI 1819479 (C-14) (Part A) and to investigate the absolute bioavailability of BI 1819479 (Part B) in healthy male volunteers.
Timeline
- Start
- 2025-08-04
- Primary completion
- 2025-10-04
- Completion
- 2025-11-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 1819479 | Unknown | — | — |
Indications
No indication recorded.